© 2010 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Submit a response
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis
CMAJ Henry et al. 180: 183

Editor's Note

In the version of this article that was released online ahead of print, the third sentence in the Methods section reads as follows: "We derived indirect risk estimates of death and myocardial infarction for aprotinin compared with lysine analogues."



This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Submit a response
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal